Sample Page Title

A medical worker holds an ampoule with the Russian drug Sputnik V («Gam-COVID-Vac») BRUSSELS, Jan 11 The European Medicines Agency EMA is currently continuing the procedure for the gradual examination of the Russian vaccine against the Sputnik V coronavirus and does not comment on the results of the work until the vaccine assessment procedure is completed, the press service of the regulator told RIA Novosti. V «, European inspectors conducted reviews of good clinical practice and good manufacturing practice in Russia during 2021. While the assessment is ongoing, EMA cannot comment on the information studied (including the results of inspections). Details of the inspection, including the inspections carried out, will be contained in the final report of the EMA «, — said the interlocutor of the agency. He added that the report will be published after the vaccine evaluation procedure is completed. Peskov assessed the success of the Sputnik vaccine in the world «The examination continues. The EMA will be able to substantively talk about the possible time frame for making a decision (on the approval of the vaccine in the EU — ed.), When the EMA task group will invite the developer (vaccine — Ed.) To submit an application to the agency Such a proposal will take into account the reliability of the data obtained as a result of the gradual examination procedure, «the EMA explained. studies of the Russian vaccine against coronavirus.